Tasly Pharmaceutical Group Co., Ltd.

Tianjin Kinsly Pharmaceutical R&d Co., Ltd.

Tasly Pharmaceuticals Group Co., Ltd.

Tianjin Tasly Pharmaceutical Co., Ltd.

Shunnan Zhang

Xijun Yan

Naifeng Wu

Kaijing Yan

Xiaohui Ma

Xiaolin Bai

Ting Li

Zhengliang Ye

Yonghong Zhu

He Sun

Yi He

Wensheng Zhang

Lihong Zhou

Hai'ou Dong

Lei Li

Lijun Fan

Yongfeng Zheng

Zhixin Guo

Yan Sun

Hongbo Zhang

Jianhui Yang

Wei Sun

Ping Li

Peng Liu

Chenming Li

Shuiping Zhou

Yan Liu

Hui Wang

Lina Dong

Xiaofeng Liu

Xiaobing Sun

Lanlan Zhang

Hua Yang

Changsheng Rong

Xiaofeng LiU

Tong Liu

Changwen Li

Lulu Yan

Jie Ma

Genbei Wang

Lihua Zhang

Bihui Wang

Bo Xu

Minchao Qi

Song Gao

Sen Lin

Cong Chen

Shiqing Wang

Lianwen Qi

Fenglian Zhang

Zhexuan Yang

Jing Yu

Henry Sun

Xingyun Shao

Changyu Ma

Hongpo Zhang

A pharmaceutical composition is prepared from the following raw materials (in parts by weight): silybin (8.75-60), phospholipid (15-65), a Pu'er tea extract (25-200), and vitamin E (6.25-40). The composition has the effect of treating non-alcoholic fatty liver diseases.

Pharmaceutical composition containing silybin and VE

Pharmaceutical composition containing silybin and ve

A traditional Chinese medicine composition for treating cardiovascular disease, and a preparation thereof, particularly a micro drop pill preparation thereof, and a method for preparing the preparation; the method for preparing the micro drop pill preparation can be used to prepare drop pills, coated drop pills, and drop pill capsules with a high drug loading capacity.

Traditional Chinese medicine composition, and preparation and application thereof

The present invention relates to a preparation method for a traditional Chinese medicine drop pill and a traditional Chinese medicine micro drop pill prepared by using the method, and in particular, the present invention relates to a micro drop pill preparation method with high drug-loading capacity, simple preparation process and high production rate and a micro drop pill prepared by using the method. Specially, The drop pill preparation method used comprises the following steps: (1) material melting step: heat melting a medicine and a drop pill matrix to obtain a molten medicine liquid; (2) dropping step: delivering the molten medicine liquid to a dripper, and acquiring medicine drops of the molten medicine liquid by means of vibration dropping; and, (3) condensation step: cooling the medicine drops with a cooling gas to obtain micro drop pills.

Formulation of a micro drop pill and the preparation method thereof

Disclosed is a pharmaceutical composition containing silibinin, which is prepared from the following bulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, and 25-200 parts of Pu'er tea extract. The drug has the function of treating non-alcoholic fatty liver.

Pharmaceutical composition containing silibinin

Disclosed are a pharmaceutical composition for treating non-alcoholic fatty liver and a method for preparing same. The composition is prepared from the following hulk drugs by weight ratio: 8.75-60 parts of silibinin, 15-65 parts of phospholipid, 25-200 parts of Pu'er tea extract, and 5-50 parts of radix puerariae extract.

Pharmaceutical composition containing silibinin and pueraria root extract

A pharmaceutical composition for treating non-alcoholic fatty liver diseases consists of a silybin-phospholipid complex preparation and Pu'er tea/tea product according to a weight ratio of 0.5-2.5:0.3-10, wherein the silybin-phospholipid complex capsule preparation and the Pu'er teat/tea product are separately packaged.

Pharmaceutical composition containing silybin

A pharmaceutical composition for treating non-alcoholic fatty liver diseases. The pharmaceutical composition is prepared from 8.75-60 parts by weight of silybin, 15-65 parts by weight of phospholipid, 25-150 parts by weight of a Pu'er tea extract, and 10.425-60 parts by weight of L-carnitine.

Pharmaceutical composition containing silybin and L-carnitine

A pharmaceutical composition. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 8.75-60 parts of silybin, 15-65 parts of phospholipid, 25-200 parts of a Pu'er tea extract, 6.25-40 parts of vitamin E, and 8.3-60 parts of L-carnitine. The composition can be used for treating non-alcoholic fatty liver diseases.

Pharmaceutical composition containing silybin, VE and L-carnitine

A traditional Chinese medicine composition and preparation thereof for treating cardiovascular diseases is provided. The traditional Chinese medicine composition consists of: by weight percentage, phenolic acid derivatives 30%&#x2dc;80%, tanshinones 2%&#x2dc;10% and saponins 15%&#x2dc;60%.

Traditional Chinese medicine composition

Traditional chinese medicine composition, and preparation and application thereof

The present invention relates to an andrographolide enteric targeting micropellet and a method for preparation thereof; furthermore, the present invention also relates to uses of andrographolide and andrographolide enteric targeting micropellets in preparation of a pharmaceutical for treatment of inflammatory bowel disease.

Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereof

A pharmaceutical composition for treating headache, prepared from eleven Chinese herbal medicines: Chinese angelica root,, prepared rhizome of rehmannia, uncaria tomentosa, leatherleaf milletia, prunella vulgaris, sicklesenna seed, pearl shell,tuber, and, and a proper amount of adjuvant materials. A preparation method of the pharmaceutical composition, and uses thereof in the preparation of drugs for treating various headaches, traumatic cranial nerve syndrome, dizziness and vertigo, vexation and irritability, insomnia and dreaminess.

Pharmaceutical composition for treating headache, and preparation method thereof

Growing community of inventors

Tianjin, China

Shunnan Zhang